Wise Management of Ovarian Cancer: On the Cutting Edge

Wise Management of Ovarian Cancer: On the Cutting Edge

Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality among women. Two-thirds of patients present at advanced stage at diagnosis, and the estimated 5 year survival rate is 20–40%. This heterogeneous group of malignancies has distinguishable etiology and molecular biology. In...

Full description

Bibliographic Details
Main Authors: Stergios Boussios, Christos Mikropoulos, Eleftherios Samartzis, Peeter Karihtala, Michele Moschetta, Matin Sheriff, Afroditi Karathanasi, Agne Sadauskaite, Elie Rassy, Nicholas Pavlidis
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Journal of Personalized Medicine
Subjects:
ovarian cancer
next-generation sequencing
homologous recombination repair
PARP inhibitors
AURK inhibitors
metformin
Online Access:https://www.mdpi.com/2075-4426/10/2/41

Internet

https://www.mdpi.com/2075-4426/10/2/41

Similar Items